nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
|
Stuver, Robert |
|
|
40 |
6 |
p. 590-591 |
artikel |
2 |
Bacterial Darth Vader: May the force be with you
|
Polyak, Kornelia |
|
|
40 |
6 |
p. 600-602 |
artikel |
3 |
Cancer vaccines
|
Schiller, John T. |
|
|
40 |
6 |
p. 559-564 |
artikel |
4 |
Combination immune checkpoint blockade in advanced untreated gastroesophageal adenocarcinoma: Seeking biomarkers for durable benefit
|
Fontana, Elisa |
|
|
40 |
6 |
p. 606-608 |
artikel |
5 |
COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge
|
Bronstein, Yotam |
|
|
40 |
6 |
p. 578-580 |
artikel |
6 |
COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
|
Parry, Helen |
|
|
40 |
6 |
p. 584-586 |
artikel |
7 |
Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma
|
Enssle, Julius C. |
|
|
40 |
6 |
p. 587-589 |
artikel |
8 |
Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer
|
Mack, Philip C. |
|
|
40 |
6 |
p. 575-577 |
artikel |
9 |
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
|
Huang, Huocong |
|
|
40 |
6 |
p. 656-673.e7 |
artikel |
10 |
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
|
Wolf, Denise M. |
|
|
40 |
6 |
p. 609-623.e6 |
artikel |
11 |
Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors
|
Cherkassky, Leonid |
|
|
40 |
6 |
p. 569-574 |
artikel |
12 |
Response-based molecular subtyping—emergence of the third generation of breast cancer subtypes
|
Denkert, Carsten |
|
|
40 |
6 |
p. 592-594 |
artikel |
13 |
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients—COVIDOUT study
|
Schönlein, Martin |
|
|
40 |
6 |
p. 581-583 |
artikel |
14 |
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma
|
Ravi, Vidhya M. |
|
|
40 |
6 |
p. 639-655.e13 |
artikel |
15 |
Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer
|
Kersten, Kelly |
|
|
40 |
6 |
p. 624-638.e9 |
artikel |
16 |
Tracing back to one of the origins of immune evasion in pancreatic cancer
|
Araos Henríquez, Joaquín |
|
|
40 |
6 |
p. 595-597 |
artikel |
17 |
Translational research: A patient-centered approach to bridge the valley of death
|
Thomas, Anish |
|
|
40 |
6 |
p. 565-568 |
artikel |
18 |
Tumor-directed dysregulation of erythroid progenitors drives immunosuppressive myeloid cells
|
Mandula, Jessica K. |
|
|
40 |
6 |
p. 597-599 |
artikel |
19 |
Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy
|
Long, Haixia |
|
|
40 |
6 |
p. 674-693.e7 |
artikel |
20 |
When immunotherapy meets surgery in non-small cell lung cancer
|
Herbst, Roy S. |
|
|
40 |
6 |
p. 603-605 |
artikel |